Levofolinic Acid for Injection(Nanjing Haina Medicine)

注射用左亚叶酸（南京海纳医药）

Report date: 2025/08/06 17:28:30

Base Information

Drug NameLevofolinic Acid for Injection(Nanjing Haina Medicine)
Drug Alias NameLevofolinic Acid注射用左亚叶酸（改良型）海复欣
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitorsThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsChemotherapy induced poisoningColorectal Neoplasms
Global Approved IndicationsChemotherapy induced poisoningColorectal Neoplasms
Approved Indications in ChinaChemotherapy induced poisoningColorectal Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2022/09/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNanjing Haina Medicine Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Haina Medicine Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy induced poisoningColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank